• Teva Pharmaceutical Industries average debt/equity ratio for 2023 was 2.35, a 13.53% increase from 2022.
• Teva Pharmaceutical Industries average debt/equity ratio for 2022 was 2.07, a 7.25% increase from 2021.
• Teva Pharmaceutical Industries average debt/equity ratio for 2021 was 1.93, a 1.05% increase from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.